On August 31, 2012, the Federal Circuit issued an en banc, per curiam opinion deciding both Akamai Technologies, Inc. v. Limelight Networks, Inc. and McKesson Technologies, Inc. v. Epic Systems Corp., which each relate to the requirements for establishing infringement when all of the steps of a method claim are not performed by a single … Continue reading this entry
Tags: Akami, BMC, Induced Infringement, McKesson, Method Claim
In AstraZeneca Pharmaceuticals LP v. Apotex Corp., the Federal Circuit held that the district court had jurisdiction over AstraZeneca’s ANDA complaint, but also held that the complaint should be dismissed for failing to state a viable claim for relief because the ANDAs included Section viii statements that carved out the methods claimed in the patents … Continue reading this entry
Tags: ANDA, AstraZeneca, Carve-Out, Crestor, Infringement, Jurisdiction, Paragraph IV, Section VIII
Posted in Federal Circuit Decisions; Infringement